Kewaunee Scientific (NASDAQ:KEQU) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Kewaunee Scientific (NASDAQ:KEQU) from a hold rating to a buy rating in a research note released on Wednesday.

Kewaunee Scientific Trading Down 1.3 %

KEQU stock opened at $53.03 on Wednesday. Kewaunee Scientific has a 52-week low of $24.49 and a 52-week high of $56.95. The company has a quick ratio of 2.00, a current ratio of 2.53 and a debt-to-equity ratio of 0.48. The firm has a market cap of $152.30 million, a P/E ratio of 8.40 and a beta of 0.80. The company’s 50-day simple moving average is $38.92 and its 200-day simple moving average is $42.40.

Insiders Place Their Bets

In other Kewaunee Scientific news, VP Elizabeth D. Phillips sold 1,850 shares of the company’s stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $54.17, for a total transaction of $100,214.50. Following the completion of the transaction, the vice president now directly owns 13,591 shares in the company, valued at approximately $736,224.47. This represents a 11.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 14.20% of the stock is currently owned by company insiders.

Institutional Trading of Kewaunee Scientific

Several institutional investors have recently modified their holdings of the stock. Ritholtz Wealth Management purchased a new position in Kewaunee Scientific in the 2nd quarter valued at about $413,000. Heron Bay Capital Management purchased a new stake in shares of Kewaunee Scientific during the second quarter worth approximately $252,000. Renaissance Technologies LLC raised its stake in Kewaunee Scientific by 13.4% in the 2nd quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock valued at $4,230,000 after purchasing an additional 10,580 shares during the last quarter. De Lisle Partners LLP lifted its holdings in Kewaunee Scientific by 36.6% in the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after purchasing an additional 11,511 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in Kewaunee Scientific by 3.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company’s stock worth $8,378,000 after purchasing an additional 6,132 shares during the last quarter. Institutional investors and hedge funds own 32.69% of the company’s stock.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.